logo
Explore dividend stocks
Add to watchlist
€1.53
Last updated:04/19/2021
2IV: F
Indivior PLC

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addicti… Show more

Dividend yield
-

Average yield for past twelve months.

P/E ratio
-

Payout ratio
-
Yearly

of earnings is used as dividends.

CASH payout ratio

Last quarter

Become our supporter to unlock all data!
Stock volatility (Beta)
past 12 months

Become our supporter to unlock all data!
Company debt level

Become our supporter to unlock all data!
2IV dividends
Payout frequency
Unknown
Latest ex-date
06/16/2016
3y growth
Unknown
5y growth
Unknown
Company results
Quarterly
Annual
Fundamentals
2017
2018
2019
2020
Net Income
Income minus expenses, depreciation, interest, taxes, and other expenses
58M
275M
+374.14%
134M
-51.27%
-148M
-210.45%
Cashflow
Sum up money going in and out company
295M
303M
+2.71%
151M
-50.17%
-193M
-227.81%
Total liabilities
All combined debts and obligations
1.647B
1.481B
-10.08%
1.443B
-2.57%
1.449B
+0.42%
Company profile
CEO
Mr. Mark Crossley
Market capitalization
Small (1.15B)